---
schema_version: "secwatch.filing_event.v1"
accession: "0001035267-26-000047"
form_type: "8-K"
ticker: "ISRG"
cik: "0001035267"
company_name: "INTUITIVE SURGICAL INC"
filed_at: "2026-07-16T20:05:17+00:00"
generated_at: "2026-07-16T20:06:14.969238+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Intuitive Surgical Q2 revenue $2.89B (+19% YoY); GAAP EPS $2.29, non-GAAP $2.80

## Summary
- Worldwide procedures grew ~16% (da Vinci +15%, Ion +36%); 468 da Vinci systems placed (246 da Vinci 5).
- GAAP net income $818M ($2.29/diluted share) vs $658M ($1.81) YoY; non-GAAP net income $1.00B ($2.80).
- Q2 included $28M net benefit from IEEPA tariff refunds; repurchased 0.9M shares for $0.38B.
- FY2026 guidance: da Vinci procedure growth ~13.5%-15.5% (closer to midpoint); non-GAAP gross margin 68%-69%.
- Non-GAAP operating expense growth guided at 11%-13%; tariff impact estimated at 1% of revenue.

## SEC filing metadata
- accession: 0001035267-26-000047
- form_type: 8-K
- ticker: ISRG
- cik: 0001035267
- company_name: INTUITIVE SURGICAL INC
- filed_at: 2026-07-16T20:05:17+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1035267/000103526726000047/0001035267-26-000047-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1035267/000103526726000047/isrg-20260716.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001035267-26-000047
- JSON: https://secwatch.observer/filing/0001035267-26-000047.json
- Plain text: https://secwatch.observer/filing/0001035267-26-000047.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.